Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT06284083 |
Other study ID # |
Cumhuriyet University Hospital |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
December 18, 2018 |
Est. completion date |
February 7, 2022 |
Study information
Verified date |
February 2024 |
Source |
Cumhuriyet University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study included 90 volunteer Obstructive Sleep Apnea Syndrome patients. Only 7 mL blood
samples collected from patients. Some biochemicals parameters analyzed in blood serum/plasma.
Description:
This study included 90 volunteer patients diagnosed with OSAS, and they were divided into
three groups according to the apnea-hypopnea index (AHI) score: mild OSAS (n=30;5≤ AHI
≤13.70), moderate (n=30;15.80≤AHI≤26.60) and severe (n=30;34.10≤AHI≤86.30). Demographic data,
as well as biochemical parameters, nocturnal oxygen saturation percentage (SpO2), and body
mass index (BMI) were measured. Plasma agmatine levels were measured by ultra-high-pressure
liquid chromatography (UHPLC), plasma trace elements (Cu, Co, Mg, Mo, Zn, Se) levels were
determind by inductively coupled plasma mass spectrometer (ICP-MS) and serum telomerase
levels were measured by enzyme-linked immunosorbent assay (ELISA) method. Analyzes were
carried out at the Cumhuriyet University advanced technology research and application center.